249 related articles for article (PubMed ID: 24093165)
1. Gastrointestinal stromal tumors: molecular markers and genetic subtypes.
Barnett CM; Corless CL; Heinrich MC
Hematol Oncol Clin North Am; 2013 Oct; 27(5):871-88. PubMed ID: 24093165
[TBL] [Abstract][Full Text] [Related]
2. [Molecular and genetic features of gastrointestinal stromal tumors (GIST)].
Buleje S J; Yábar B A; Guevara-Fujita M; Fujita R
Rev Gastroenterol Peru; 2012; 32(4):394-9. PubMed ID: 23307090
[TBL] [Abstract][Full Text] [Related]
3. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
[TBL] [Abstract][Full Text] [Related]
4. High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors.
Künstlinger H; Binot E; Merkelbach-Bruse S; Huss S; Wardelmann E; Buettner R; Schildhaus HU
Hum Pathol; 2014 Mar; 45(3):573-82. PubMed ID: 24444465
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
Lasota J; Miettinen M
Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
[TBL] [Abstract][Full Text] [Related]
6. The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor.
Schaefer IM; DeMatteo RP; Serrano C
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-15. PubMed ID: 35522913
[TBL] [Abstract][Full Text] [Related]
7. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
Nannini M; Biasco G; Astolfi A; Pantaleo MA
J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
[TBL] [Abstract][Full Text] [Related]
8. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
[TBL] [Abstract][Full Text] [Related]
9. Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors.
Yan W; Zhang A; Powell MJ
Chin J Cancer; 2016 Jul; 35(1):68. PubMed ID: 27443349
[TBL] [Abstract][Full Text] [Related]
10. Biology of gastrointestinal stromal tumors.
Corless CL; Fletcher JA; Heinrich MC
J Clin Oncol; 2004 Sep; 22(18):3813-25. PubMed ID: 15365079
[TBL] [Abstract][Full Text] [Related]
11. [Application and value of mutation detection in diagnosis and treatment of gastrointestinal stromal tumor].
Cao H; Wang M
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):208-11. PubMed ID: 23536336
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors.
Daum O; Grossmann P; Vanecek T; Sima R; Mukensnabl P; Michal M
Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304
[TBL] [Abstract][Full Text] [Related]
13. miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers.
Nannini M; Ravegnini G; Angelini S; Astolfi A; Biasco G; Pantaleo MA
Epigenomics; 2015; 7(6):1033-49. PubMed ID: 26447534
[TBL] [Abstract][Full Text] [Related]
14. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testing.
Künstlinger H; Huss S; Merkelbach-Bruse S; Binot E; Kleine MA; Loeser H; Mittler J; Hartmann W; Hohenberger P; Reichardt P; Büttner R; Wardelmann E; Schildhaus HU
Am J Surg Pathol; 2013 Nov; 37(11):1648-59. PubMed ID: 24061512
[TBL] [Abstract][Full Text] [Related]
16. New targets and therapies for gastrointestinal stromal tumors.
Wozniak A; Gebreyohannes YK; Debiec-Rychter M; Schöffski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1117-1129. PubMed ID: 29110548
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for the treatment of gastrointestinal stromal tumour.
Kasireddy V; von Mehren M
Expert Opin Emerg Drugs; 2017 Dec; 22(4):317-329. PubMed ID: 29183145
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of the FGF/FGFR Pathway in Gastrointestinal Stromal Tumor.
Astolfi A; Pantaleo MA; Indio V; Urbini M; Nannini M
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392832
[TBL] [Abstract][Full Text] [Related]
19. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
20. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
